Overview

This trial is active, not recruiting.

Condition dystrophinopathies
Sponsor Cooperative International Neuromuscular Research Group
Start date May 2014
End date December 2016
Trial size 55 participants
Trial identifier NCT02146586, CNMC0713

Summary

This study outlines structured Clinical Evaluator (CE) testing techniques that are proposed to be implemented across all sites participating in the Cooperative International Neuromuscular Research Group (CINRG) research studies. The study will determine if the selected techniques are reliable and reproducible across the CINRG network by evaluating the reliability and reproducibility of the measures between CEs

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Arm

Primary Outcomes

Measure
Clinical Evaluator Assessments
time frame: One time visit

Eligibility Criteria

Male participants at least 6 years old.

Dystrophinopathy Participant Inclusion Criteria: - Site confirmed genetic diagnosis of a dystrophinopathy - Aged 6 years and older - Able to transfer to testing table - Able to walk 10 meters without an assistive device Dystrophinopathy Participant Exclusion Criteria: - Investigator assessment of inability to comply with protocol assessments - Participants who have attention deficient disorder or other cognitive conditions that may limit attention span to perform protocol assessments

Additional Information

Official title Cooperative International Neuromuscular Research Group (CINRG) Clinical Evaluator Outcomes Reliability Study
Principal investigator Lauren Morgenroth, MS, CGC
Trial information was received from ClinicalTrials.gov and was last updated in February 2016.
Information provided to ClinicalTrials.gov by Cooperative International Neuromuscular Research Group.